Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against DocuSign, Inc. (“DocuSign” or the “Company”) (NASDAQ: DOCU) in the United States District Court for the Eastern District of New York on behalf of all persons and entities who purchased or otherwise acquired DocuSign securities between March 27, 2020 and December 2, 2021, both dates inclusive (the “Class Period”). Investors have until February 21, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Click here to participate in the action.

The complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) the impact of the Covid-19 pandemic on DocuSign's business was positive, not negative; (2) DocuSign misrepresented the role that the Covid-19 pandemic had on its growth; (3) DocuSign downplayed the impact that a "return to normal" would have on the Company's growth and business; and (4) as a result, defendants' public statements were materially false and misleading at all relevant times.

On this news, DocuSign's stock price plummeted $98.73 per share, or over 42%, to close at $135.09 per share on December 3, 2021, damaging investors.

If you purchased or otherwise acquired DocuSign shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Alexandra Raymond by email at investigations@bespc.com, telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.